New Findings: • Castleman Disease can progress from a unicentric to a multicentric form in children. • Subcutaneous tocilizumab is a safe and effective ther apy for patients with Castleman Disease, improving quality of life and eliminating the need for frequent hospital admissions for intravenous infusions
Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease Progressing From Unicentric to Multicentric Form / Naviglio, S., Nicolardi, F., Bussani, R., Tommasini, A., Barbi, E., Rabusin, M.. - In: JOURNAL OF PAEDIATRICS AND CHILD HEALTH. - ISSN 1034-4810. - 62:7(2026), pp. 1255-1258. [10.1111/jpc.70404]
Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease Progressing From Unicentric to Multicentric Form
Naviglio, SamuelePrimo
;Nicolardi, Francesca
Secondo
;Bussani, Rossana;Tommasini, Alberto;Barbi, EgidioPenultimo
;
2026-01-01
Abstract
New Findings: • Castleman Disease can progress from a unicentric to a multicentric form in children. • Subcutaneous tocilizumab is a safe and effective ther apy for patients with Castleman Disease, improving quality of life and eliminating the need for frequent hospital admissions for intravenous infusionsFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
J Paediatrics Child Health - 2026 - Naviglio - Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
731.54 kB
Formato
Adobe PDF
|
731.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
